Business Description
Pulse Biosciences Inc
NAICS : 339113
SIC : 3841
ISIN : US74587B1017
Description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.45 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | -0.18 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 25.1 | |||||
| 3-Year EPS without NRI Growth Rate | 25.6 | |||||
| 3-Year FCF Growth Rate | 23.5 | |||||
| 3-Year Book Growth Rate | -3.5 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.05 | |||||
| 9-Day RSI | 68.1 | |||||
| 14-Day RSI | 63.88 | |||||
| 6-1 Month Momentum % | 30.68 | |||||
| 12-1 Month Momentum % | 87.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.93 | |||||
| Quick Ratio | 11.93 | |||||
| Cash Ratio | 11.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.2 | |||||
| Shareholder Yield % | 2.55 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -96.56 | |||||
| ROA % | -74.96 | |||||
| ROIC % | -282.72 | |||||
| ROC (Joel Greenblatt) % | -573.93 | |||||
| ROCE % | -87.34 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 16.64 | |||||
| Price-to-Tangible-Book | 17.57 | |||||
| EV-to-EBIT | -25.67 | |||||
| EV-to-EBITDA | -26.32 | |||||
| EV-to-Forward-Revenue | 7.94 | |||||
| EV-to-FCF | -36.54 | |||||
| Price-to-Net-Current-Asset-Value | 19.79 | |||||
| Price-to-Net-Cash | 20.22 | |||||
| Earnings Yield (Greenblatt) % | -3.9 | |||||
| FCF Yield % | -2.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pulse Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.745 | ||
| Beta | 2.63 | ||
| Volatility % | 127.52 | ||
| 14-Day RSI | 63.88 | ||
| 14-Day ATR (€) | 0.749024 | ||
| 20-Day SMA (€) | 16.46 | ||
| 12-1 Month Momentum % | 87.81 | ||
| 52-Week Range (€) | 6.029275 - 19.3 | ||
| Shares Outstanding (Mil) | 61.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pulse Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pulse Biosciences Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pulse Biosciences Inc Frequently Asked Questions
What is Pulse Biosciences Inc(STU:6L8)'s stock price today?
The current price of STU:6L8 is €18.80. The 52 week high of STU:6L8 is €19.30 and 52 week low is €6.03.
When is next earnings date of Pulse Biosciences Inc(STU:6L8)?
The next earnings date of Pulse Biosciences Inc(STU:6L8) is 2025-03-28 Est..
Does Pulse Biosciences Inc(STU:6L8) pay dividends? If so, how much?
Pulse Biosciences Inc(STU:6L8) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers